Pnc Financial Services Group, Inc. Clearside Biomedical, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 107,919 shares of CLSD stock, worth $94,968. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107,919
Previous 5,586
1831.95%
Holding current value
$94,968
Previous $7,000
1857.14%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CLSD
# of Institutions
55Shares Held
12.2MCall Options Held
54.7KPut Options Held
50.7K-
Vanguard Group Inc Valley Forge, PA2.84MShares$2.5 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.93 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.93MShares$1.7 Million0.04% of portfolio
-
Black Rock Inc. New York, NY798KShares$702,3600.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny745KShares$655,5020.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $53M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...